Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asher

Showing results (111-120 of 6,821) with videos related to

Pageof 683
Sort By:
Nature Biotechnology|March 10, 2009
Alnylam dealt blowAsher Mullard
Nature Reviews. Drug Discovery|February 28, 2025
Induced proximity pushes beyond protein degraders, as first RIPTAC moves into the clinicAsher Mullard
Nature Reviews. Drug Discovery|December 3, 2024
FDA approves first menin inhibitor, for acute leukaemiaAsher Mullard
Nature Reviews. Drug Discovery|December 18, 2024
FDA approves first HER2 × HER3 bispecific antibodyAsher Mullard
Nature Reviews. Drug Discovery|September 14, 2023
Pushing both sides of the drug pricing aisleAsher Mullard
Nature Reviews. Drug Discovery|October 6, 2023
Novel schizophrenia therapy filed for FDA approvalAsher Mullard
Nature Reviews. Drug Discovery|February 18, 2025
Can large, simple trials bring drug developers back to common diseases?Asher Mullard
Nature Reviews. Drug Discovery|January 8, 2020
RNAi agents score an approval and drive an acquisitionAsher Mullard
Nature Reviews. Drug Discovery|March 24, 2020
Ted W. LoveAsher Mullard
Nature Reviews. Drug Discovery|October 6, 2020
Amgen cues up pivotal KRAS dataAsher Mullard
Pageof 683

Showing results (111-120 of 6,821) with videos related to

Sort By:
Pageof 683
Nature Biotechnology|March 10, 2009
Alnylam dealt blowAsher Mullard
Nature Reviews. Drug Discovery|February 28, 2025
Induced proximity pushes beyond protein degraders, as first RIPTAC moves into the clinicAsher Mullard
Nature Reviews. Drug Discovery|December 3, 2024
FDA approves first menin inhibitor, for acute leukaemiaAsher Mullard
Nature Reviews. Drug Discovery|December 18, 2024
FDA approves first HER2 × HER3 bispecific antibodyAsher Mullard
Nature Reviews. Drug Discovery|September 14, 2023
Pushing both sides of the drug pricing aisleAsher Mullard
Nature Reviews. Drug Discovery|October 6, 2023
Novel schizophrenia therapy filed for FDA approvalAsher Mullard
Nature Reviews. Drug Discovery|February 18, 2025
Can large, simple trials bring drug developers back to common diseases?Asher Mullard
Nature Reviews. Drug Discovery|January 8, 2020
RNAi agents score an approval and drive an acquisitionAsher Mullard
Nature Reviews. Drug Discovery|March 24, 2020
Ted W. LoveAsher Mullard
Nature Reviews. Drug Discovery|October 6, 2020
Amgen cues up pivotal KRAS dataAsher Mullard
Pageof 683